IBDEI083 ; ; 13-FEB-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 13, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10628,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10628,1,3,0)
 ;;=3^Glaucoma,Residual Open Angle
 ;;^UTILITY(U,$J,358.3,10628,1,4,0)
 ;;=4^365.15
 ;;^UTILITY(U,$J,358.3,10628,2)
 ;;=Residual Open Angle Glaucoma^268751
 ;;^UTILITY(U,$J,358.3,10629,0)
 ;;=365.31^^72^694^32
 ;;^UTILITY(U,$J,358.3,10629,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10629,1,3,0)
 ;;=3^Glaucoma,Steroid Induced
 ;;^UTILITY(U,$J,358.3,10629,1,4,0)
 ;;=4^365.31
 ;;^UTILITY(U,$J,358.3,10629,2)
 ;;=Steroid Induced Glaucoma^268761
 ;;^UTILITY(U,$J,358.3,10630,0)
 ;;=365.61^^72^694^11
 ;;^UTILITY(U,$J,358.3,10630,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10630,1,3,0)
 ;;=3^Glaucoma W/Pupillary Block
 ;;^UTILITY(U,$J,358.3,10630,1,4,0)
 ;;=4^365.61
 ;;^UTILITY(U,$J,358.3,10630,2)
 ;;=Glaucoma W/Pupillary Block^268776
 ;;^UTILITY(U,$J,358.3,10631,0)
 ;;=365.23^^72^694^13
 ;;^UTILITY(U,$J,358.3,10631,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10631,1,3,0)
 ;;=3^Glaucoma,Chr Angle Closure
 ;;^UTILITY(U,$J,358.3,10631,1,4,0)
 ;;=4^365.23
 ;;^UTILITY(U,$J,358.3,10631,2)
 ;;=^268756
 ;;^UTILITY(U,$J,358.3,10632,0)
 ;;=363.71^^72^694^43
 ;;^UTILITY(U,$J,358.3,10632,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10632,1,3,0)
 ;;=3^Serous Choroidal Detachment
 ;;^UTILITY(U,$J,358.3,10632,1,4,0)
 ;;=4^363.71
 ;;^UTILITY(U,$J,358.3,10632,2)
 ;;=Choroidal Detachment^268699
 ;;^UTILITY(U,$J,358.3,10633,0)
 ;;=365.51^^72^694^24
 ;;^UTILITY(U,$J,358.3,10633,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10633,1,3,0)
 ;;=3^Glaucoma,Phacolytic
 ;;^UTILITY(U,$J,358.3,10633,1,4,0)
 ;;=4^365.51
 ;;^UTILITY(U,$J,358.3,10633,2)
 ;;=Phacolytic Glaucoma^265226
 ;;^UTILITY(U,$J,358.3,10634,0)
 ;;=365.01^^72^694^21
 ;;^UTILITY(U,$J,358.3,10634,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10634,1,3,0)
 ;;=3^Glaucoma,Open Angle Suspect
 ;;^UTILITY(U,$J,358.3,10634,1,4,0)
 ;;=4^365.01
 ;;^UTILITY(U,$J,358.3,10634,2)
 ;;=Open Angle Glaucoma Suspect^268747
 ;;^UTILITY(U,$J,358.3,10635,0)
 ;;=365.04^^72^694^37
 ;;^UTILITY(U,$J,358.3,10635,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10635,1,3,0)
 ;;=3^Ocular Hypertension
 ;;^UTILITY(U,$J,358.3,10635,1,4,0)
 ;;=4^365.04
 ;;^UTILITY(U,$J,358.3,10635,2)
 ;;=Ocular Hypertension^85124
 ;;^UTILITY(U,$J,358.3,10636,0)
 ;;=365.03^^72^694^44
 ;;^UTILITY(U,$J,358.3,10636,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10636,1,3,0)
 ;;=3^Steroid Responder
 ;;^UTILITY(U,$J,358.3,10636,1,4,0)
 ;;=4^365.03
 ;;^UTILITY(U,$J,358.3,10636,2)
 ;;=^268749
 ;;^UTILITY(U,$J,358.3,10637,0)
 ;;=366.11^^72^694^41
 ;;^UTILITY(U,$J,358.3,10637,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10637,1,3,0)
 ;;=3^Pseudoexfoliation w/o Glaucoma
 ;;^UTILITY(U,$J,358.3,10637,1,4,0)
 ;;=4^366.11
 ;;^UTILITY(U,$J,358.3,10637,2)
 ;;=^265538
 ;;^UTILITY(U,$J,358.3,10638,0)
 ;;=365.02^^72^694^1
 ;;^UTILITY(U,$J,358.3,10638,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10638,1,3,0)
 ;;=3^Anatomic Narrow Angle
 ;;^UTILITY(U,$J,358.3,10638,1,4,0)
 ;;=4^365.02
 ;;^UTILITY(U,$J,358.3,10638,2)
 ;;=Anatomic Narrow Angle^268748
 ;;^UTILITY(U,$J,358.3,10639,0)
 ;;=364.53^^72^694^39
 ;;^UTILITY(U,$J,358.3,10639,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10639,1,3,0)
 ;;=3^Pigment Dispersion w/o Glauc
 ;;^UTILITY(U,$J,358.3,10639,1,4,0)
 ;;=4^364.53
 ;;^UTILITY(U,$J,358.3,10639,2)
 ;;=^268720
 ;;^UTILITY(U,$J,358.3,10640,0)
 ;;=364.42^^72^694^42
 ;;^UTILITY(U,$J,358.3,10640,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10640,1,3,0)
 ;;=3^Rubeosis Iridis w/o Glaucoma
 ;;^UTILITY(U,$J,358.3,10640,1,4,0)
 ;;=4^364.42
 ;;^UTILITY(U,$J,358.3,10640,2)
 ;;=Rubeosis Iridis w/o Glaucoma^268716
 ;;^UTILITY(U,$J,358.3,10641,0)
 ;;=364.77^^72^694^2
 ;;^UTILITY(U,$J,358.3,10641,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10641,1,3,0)
 ;;=3^Angle Recession w/o Glauc
 ;;^UTILITY(U,$J,358.3,10641,1,4,0)
 ;;=4^364.77
 ;;^UTILITY(U,$J,358.3,10641,2)
 ;;=Angle Recession w/o Glauc^268743
 ;;^UTILITY(U,$J,358.3,10642,0)
 ;;=368.40^^72^694^45
 ;;^UTILITY(U,$J,358.3,10642,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10642,1,3,0)
 ;;=3^Visual Field Defect
 ;;^UTILITY(U,$J,358.3,10642,1,4,0)
 ;;=4^368.40
 ;;^UTILITY(U,$J,358.3,10642,2)
 ;;=Visual Field Defect^126859
 ;;^UTILITY(U,$J,358.3,10643,0)
 ;;=363.70^^72^694^4
 ;;^UTILITY(U,$J,358.3,10643,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10643,1,3,0)
 ;;=3^Choroidal Detachment NOS
 ;;^UTILITY(U,$J,358.3,10643,1,4,0)
 ;;=4^363.70
 ;;^UTILITY(U,$J,358.3,10643,2)
 ;;=^276841
 ;;^UTILITY(U,$J,358.3,10644,0)
 ;;=365.24^^72^694^28
 ;;^UTILITY(U,$J,358.3,10644,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10644,1,3,0)
 ;;=3^Glaucoma,Residual Angle Closure
 ;;^UTILITY(U,$J,358.3,10644,1,4,0)
 ;;=4^365.24
 ;;^UTILITY(U,$J,358.3,10644,2)
 ;;=^268758
 ;;^UTILITY(U,$J,358.3,10645,0)
 ;;=365.65^^72^694^34
 ;;^UTILITY(U,$J,358.3,10645,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10645,1,3,0)
 ;;=3^Glaucoma,Traumatic
 ;;^UTILITY(U,$J,358.3,10645,1,4,0)
 ;;=4^365.65
 ;;^UTILITY(U,$J,358.3,10645,2)
 ;;=^268780
 ;;^UTILITY(U,$J,358.3,10646,0)
 ;;=365.89^^72^694^23
 ;;^UTILITY(U,$J,358.3,10646,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10646,1,3,0)
 ;;=3^Glaucoma,Oth Specified
 ;;^UTILITY(U,$J,358.3,10646,1,4,0)
 ;;=4^365.89
 ;;^UTILITY(U,$J,358.3,10646,2)
 ;;=^88069
 ;;^UTILITY(U,$J,358.3,10647,0)
 ;;=365.05^^72^694^38
 ;;^UTILITY(U,$J,358.3,10647,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10647,1,3,0)
 ;;=3^Opn Ang w/ brdrlne fnd-Hi Risk
 ;;^UTILITY(U,$J,358.3,10647,1,4,0)
 ;;=4^365.05
 ;;^UTILITY(U,$J,358.3,10647,2)
 ;;=^340511
 ;;^UTILITY(U,$J,358.3,10648,0)
 ;;=365.06^^72^694^40
 ;;^UTILITY(U,$J,358.3,10648,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10648,1,3,0)
 ;;=3^Prim Ang Clos w/o Glauc Dmg
 ;;^UTILITY(U,$J,358.3,10648,1,4,0)
 ;;=4^365.06
 ;;^UTILITY(U,$J,358.3,10648,2)
 ;;=^340512
 ;;^UTILITY(U,$J,358.3,10649,0)
 ;;=365.70^^72^694^31
 ;;^UTILITY(U,$J,358.3,10649,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10649,1,3,0)
 ;;=3^Glaucoma,Stage NOS
 ;;^UTILITY(U,$J,358.3,10649,1,4,0)
 ;;=4^365.70
 ;;^UTILITY(U,$J,358.3,10649,2)
 ;;=^340609
 ;;^UTILITY(U,$J,358.3,10650,0)
 ;;=365.71^^72^694^17
 ;;^UTILITY(U,$J,358.3,10650,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10650,1,3,0)
 ;;=3^Glaucoma,Mild Stage
 ;;^UTILITY(U,$J,358.3,10650,1,4,0)
 ;;=4^365.71
 ;;^UTILITY(U,$J,358.3,10650,2)
 ;;=^340513
 ;;^UTILITY(U,$J,358.3,10651,0)
 ;;=365.72^^72^694^18
 ;;^UTILITY(U,$J,358.3,10651,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10651,1,3,0)
 ;;=3^Glaucoma,Moderate Stage
 ;;^UTILITY(U,$J,358.3,10651,1,4,0)
 ;;=4^365.72
 ;;^UTILITY(U,$J,358.3,10651,2)
 ;;=^340514
 ;;^UTILITY(U,$J,358.3,10652,0)
 ;;=365.73^^72^694^30
 ;;^UTILITY(U,$J,358.3,10652,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10652,1,3,0)
 ;;=3^Glaucoma,Severe Stage
 ;;^UTILITY(U,$J,358.3,10652,1,4,0)
 ;;=4^365.73
 ;;^UTILITY(U,$J,358.3,10652,2)
 ;;=^340515
 ;;^UTILITY(U,$J,358.3,10653,0)
 ;;=365.74^^72^694^14
 ;;^UTILITY(U,$J,358.3,10653,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10653,1,3,0)
 ;;=3^Glaucoma,Indeterm Stage
 ;;^UTILITY(U,$J,358.3,10653,1,4,0)
 ;;=4^365.74
 ;;^UTILITY(U,$J,358.3,10653,2)
 ;;=^340516
 ;;^UTILITY(U,$J,358.3,10654,0)
 ;;=V19.11^^72^694^5
 ;;^UTILITY(U,$J,358.3,10654,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10654,1,3,0)
 ;;=3^Family Hx Glaucoma
 ;;^UTILITY(U,$J,358.3,10654,1,4,0)
 ;;=4^V19.11
 ;;^UTILITY(U,$J,358.3,10654,2)
 ;;=^340617
 ;;^UTILITY(U,$J,358.3,10655,0)
 ;;=V19.19^^72^694^6
 ;;^UTILITY(U,$J,358.3,10655,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10655,1,3,0)
 ;;=3^Family Hx Oth Spec Eye Disord
 ;;^UTILITY(U,$J,358.3,10655,1,4,0)
 ;;=4^V19.19
 ;;^UTILITY(U,$J,358.3,10655,2)
 ;;=^340618
 ;;^UTILITY(U,$J,358.3,10656,0)
 ;;=365.62^^72^694^8
 ;;^UTILITY(U,$J,358.3,10656,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10656,1,3,0)
 ;;=3^Glauc Assoc w/ Ocular Inflamm
 ;;^UTILITY(U,$J,358.3,10656,1,4,0)
 ;;=4^365.62
 ;;^UTILITY(U,$J,358.3,10656,2)
 ;;=^268777
 ;;^UTILITY(U,$J,358.3,10657,0)
 ;;=365.00^^72^694^33
 ;;^UTILITY(U,$J,358.3,10657,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10657,1,3,0)
 ;;=3^Glaucoma,Suspects
 ;;^UTILITY(U,$J,358.3,10657,1,4,0)
 ;;=4^365.00
 ;;^UTILITY(U,$J,358.3,10657,2)
 ;;=^97584
 ;;^UTILITY(U,$J,358.3,10658,0)
 ;;=365.60^^72^694^10
 ;;^UTILITY(U,$J,358.3,10658,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10658,1,3,0)
 ;;=3^Glauc w/ Unspec Ocular D/O
 ;;^UTILITY(U,$J,358.3,10658,1,4,0)
 ;;=4^365.60
 ;;^UTILITY(U,$J,358.3,10658,2)
 ;;=^268775
 ;;^UTILITY(U,$J,358.3,10659,0)
 ;;=365.9^^72^694^35
 ;;^UTILITY(U,$J,358.3,10659,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10659,1,3,0)
 ;;=3^Glaucoma,Unspec
 ;;^UTILITY(U,$J,358.3,10659,1,4,0)
 ;;=4^365.9
 ;;^UTILITY(U,$J,358.3,10659,2)
 ;;=^51160
 ;;^UTILITY(U,$J,358.3,10660,0)
 ;;=365.22^^72^694^12
 ;;^UTILITY(U,$J,358.3,10660,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10660,1,3,0)
 ;;=3^Glaucoma,Acute Angle Closure
 ;;^UTILITY(U,$J,358.3,10660,1,4,0)
 ;;=4^365.22
 ;;^UTILITY(U,$J,358.3,10660,2)
 ;;=^268754
 ;;^UTILITY(U,$J,358.3,10661,0)
 ;;=365.59^^72^694^7
 ;;^UTILITY(U,$J,358.3,10661,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10661,1,3,0)
 ;;=3^Glauc Assoc w/ Lens D/O
 ;;^UTILITY(U,$J,358.3,10661,1,4,0)
 ;;=4^365.59
 ;;^UTILITY(U,$J,358.3,10661,2)
 ;;=^268773
 ;;^UTILITY(U,$J,358.3,10662,0)
 ;;=365.44^^72^694^9
 ;;^UTILITY(U,$J,358.3,10662,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10662,1,3,0)
 ;;=3^Glauc Assoc w/ Systemic Syndromes
 ;;^UTILITY(U,$J,358.3,10662,1,4,0)
 ;;=4^365.44
 ;;^UTILITY(U,$J,358.3,10662,2)
 ;;=^268769
 ;;^UTILITY(U,$J,358.3,10663,0)
 ;;=377.14^^72^694^36
 ;;^UTILITY(U,$J,358.3,10663,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10663,1,3,0)
 ;;=3^Glaucomatous Atrophy
 ;;^UTILITY(U,$J,358.3,10663,1,4,0)
 ;;=4^377.14
 ;;^UTILITY(U,$J,358.3,10663,2)
 ;;=^269218
 ;;^UTILITY(U,$J,358.3,10664,0)
 ;;=365.14^^72^694^15
